Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library
Nasim Shahhamzehei, Sara Abdelfatah, Thomas Efferth
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 308-308
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25
Diketopiperazine/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library
Nasim Shahhamzehei, Sara Abdelfatah, Ejlal A. Omer, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117841-117841
Closed Access
Exploring the mechanism of Radix Bupleuri in the treatment of depression combined with SARS-CoV-2 infection through bioinformatics, network pharmacology, molecular docking, and molecular dynamic simulation
Zexing Chen, Xinhua Wang, Wanyi Huang
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Microscale Thermophoresis as a Tool to Study Protein Interactions and Their Implication in Human Diseases
Romain Magnez, Christian Bailly, Xavier Thuru
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7672-7672
Open Access | Times Cited: 22
Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100125-100125
Open Access | Times Cited: 14
SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts
Manoj S. Nair, Yiming Huang, M. Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116291-116291
Open Access | Times Cited: 12
Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study
Deblina Rababi, Anish Nag
3 Biotech (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 8
Molecular docking and dynamics simulation study of medicinal fungi derived secondary metabolites as potential inhibitor for COVID-19 treatment
Md Abu Sayem Khan, Md Ibrahim Miah, Zahidul Islam, et al.
Informatics in Medicine Unlocked (2023) Vol. 41, pp. 101305-101305
Open Access | Times Cited: 8
Galangal–Cinnamon Spice Mixture Blocks the Coronavirus Infection Pathway through Inhibition of SARS-CoV-2 MPro, Three HCoV-229E Targets; Quantum-Chemical Calculations Support In Vitro Evaluation
Doaa G. El-Hosari, Wesam M. Hussein, Marwa O. Elgendy, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1378-1378
Open Access | Times Cited: 8
Antiviral activity of luteolin against porcine epidemic diarrhea virus in silico and in vitro
Jieru Wang, Xiaoyu Zeng, Jiaojiao Gou, et al.
BMC Veterinary Research (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus
Shaza S. Issa, С. В. Сокорнова, Roman R. Zhidkin, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1862-1862
Open Access | Times Cited: 14
Renoprotective Effects of Luteolin: Therapeutic Potential for COVID-19-Associated Acute Kidney Injuries
Lúcio Ricardo Leite Diniz, Hatem A. Elshabrawy, Marilia Trindade S. Souza, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1544-1544
Open Access | Times Cited: 13
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zhonglei Wang, Xian-qing Song, Wenjing Xu, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3885-3885
Open Access | Times Cited: 7
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease
Norman Tran, Sathish Dasari, Sarah Barwell, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein
Kalliopi Moschovou, Μαρία Αντωνίου, Eleni Chontzopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15894-15894
Open Access | Times Cited: 5
Computational aids for assessing bioactivities in phytochemical and natural products research
Evelyn Wolfram, Adriana Trifan
Elsevier eBooks (2024), pp. 357-393
Closed Access | Times Cited: 1
Molecular mechanisms of human coronavirus NL63 infection and replication
Gino Castillo, Juan Carlos Mora-Díaz, Mary Breuer, et al.
Virus Research (2023) Vol. 327, pp. 199078-199078
Open Access | Times Cited: 4
Applications of the Microscale Thermophoresis Binding Assay in COVID-19 Research
Damian T. Nydegger, Jonai Pujol‐Giménez, Palanivel Kandasamy, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1432-1432
Open Access | Times Cited: 3
Eryngium creticum L.: Chemical Characterization, SARS-CoV-2 Inhibitory Activity, and In Silico Study
Marwa Elsbaey, Mahmoud A. A. Ibrahim, Ahmed M. Shawky, et al.
ACS Omega (2022) Vol. 7, Iss. 26, pp. 22725-22734
Open Access | Times Cited: 6
Artemisinin as a therapeutic vs. its more complex Artemisia source material
Pamela J. Weathers
Natural Product Reports (2022) Vol. 40, Iss. 7, pp. 1158-1169
Closed Access | Times Cited: 6
Computer-aided Drug Discovery Approaches in the Identification of Natural Products against SARS-CoV-2: A Review
Mariana Martinelli Junqueira Ribeiro
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 4, pp. 313-324
Closed Access | Times Cited: 2
Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening
Vikrant Kumar, Puneeth Kumar Chunchagatta Lakshman, T.K. Prasad, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23864-e23864
Open Access | Times Cited: 2
Flavonoids as potential SARS-CoV-2 main protease inhibitors: In vitro activity evaluation, molecular docking, 3D-QSAR investigation and synthesis
Shuaiwei Ren, Xiaoru Liu, Yousheng Huang, et al.
Journal of Molecular Structure (2024), pp. 140286-140286
Closed Access
In silico design and discovery of pan coronavirus small molecule anti-virals targeting 3CL PRO protease
Satish Kumar Manjhi, Aman Achuthan Kattuparambil, Bibhudutta Mishra, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access
SARS-CoV-2 omicron variants succumbin vitrotoArtemisia annuahot water extracts
Manoj S. Nair, Yiming Huang, Pamela J. Weathers
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top